EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2/MEK2/ERK2 pathway

Nan Wu, Yang Wu, Qian Zhang, Muhammad Naeem, Ren Jing, Yuan-Bin Luo, Shijian Yi

Frontiers in Endocrinology · 2026

DOI: 10.3389/fendo.2026.1739944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Nan Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University, Shenzhen, China. Hauptthemen laut MEDLINE: Flavanones, Thyroid Neoplasms, Proto-Oncogene Proteins, MAP Kinase Kinase Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Papillary thyroid cancer (PTC) is the most common type of endocrine malignancy caused by genetic mutations, hormonal imbalances, and environmental factors. However, recurrent infections, and metastasis in PTC patients remain challenged due to complexity of traditional methods. Baicalein (BA) is a kind of natural flavonoid that exhibits the anti-cancer, anti-inflammatory, anti-tumor, and anti-viral activities. The molecular mechanism of baicalein in pathogenesis of PTC remains unclear. This study was designed to explore the inhibitory effects of BA against PTC by mediating the Golgi apparatus reprogramming via PLAU and suppressing the TPL2/MEK2/ERK2 pathway.

Methods

Transcriptomic analysis was performed to explore the gene expression profiles. Molecular docking was employed to identify the potential targets to elucidate the molecular mechanism of action of BA.

Results

PLAU, an up-regulated DEG, is implicated in tumor development, lymph node metastasis, and infiltration levels of neutrophils and dendritic cells in thyroid cancer patients. Molecular docking analysis revealed that serum levels of uPA protein encoded by PLAU and Plau mRNA were elevated in PTC patients with metastasis and BRAF mutation. BA treatment upregulates PLAU gene expression, but this increased PLAU protein subsequently interacts with and inhibited by BA, leading to downstream pathway suppression.

Conclusion

It was concluded it could be served as a promising therapeutic strategy for the treatment of PTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesThyroid NeoplasmsProto-Oncogene ProteinsMAP Kinase Kinase KinasesMAP Kinase Kinase 2Mitogen-Activated Protein Kinase 1MAP Kinase Signaling SystemThyroid Cancer, PapillaryHumansMolecular Docking SimulationAnimalsDisease ProgressionSignal TransductionGene Expression Regulation, NeoplasticCell Line, TumorCell ProliferationMice

Stichwörter der Autor:innen

Golgi apparatusMAPK pathwayPLAUPTCbaicaleinthyroid cancer

Substanzen

baicaleinFlavanonesProto-Oncogene ProteinsMAP Kinase Kinase KinasesMAP3K8 protein, humanMAP Kinase Kinase 2Mitogen-Activated Protein Kinase 1MAPK1 protein, human

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
  • Respiratory Medicine, Shenzhen Pingle Orthopedic Hospital, Shenzhen, China.

Zitieren

APA

Wu, N., Wu, Y., Zhang, Q., Naeem, M., Jing, R., Luo, Y. B., & Yi, S. (2026). Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2/MEK2/ERK2 pathway. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1739944

Vancouver

Wu N, Wu Y, Zhang Q, Naeem M, Jing R, Luo YB, et al. Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2/MEK2/ERK2 pathway. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1739944

BibTeX
@article{Wu2026,
  author = {Wu, Nan and Wu, Yang and Zhang, Qian and Naeem, Muhammad and Jing, Ren and Luo, Yuan-Bin and Yi, Shijian},
  title = {Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2/MEK2/ERK2 pathway},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  doi = {10.3389/fendo.2026.1739944}
}
Kostenlos starten →